日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Anti-progestin therapy targets hallmarks of breast cancer risk.

抗孕激素疗法针对乳腺癌风险的标志性特征。

Simões Bruno M, Pedley Robert, McCloskey Curtis W, Roberts Matthew, Reed Austin D, Twigger Alecia-Jane, Tharmapalan Pirashaanthy, Caruso Amanda, Cabral Sara, Wilby Anthony J, Harrison Hannah, Zhou Yuxi, Greenhalgh Alice, Alghamdi Suad A, Forestiero Martina, Lopez-Muñoz Jesica, Roche Jasmin, Tuieng Ren Jie, Khan Muhammad A, Squires Steven, Astley Susan M, Harkness Elaine F, Santiago-Gómez Angélica, Spence Katherine, Ritchie Jessica, Pritchard Susan, Lim Yit, Sherratt Michael J, Andò Sebastiano, Howell Anthony, Evans D Gareth, Gilmore Andrew P, Khaled Walid T, Khokha Rama, Clarke Robert B, Howell Sacha J

Adipocyte/Tumor cell crosstalk via IGF-1/TXNIP axis promotes malignancy and endocrine resistance in breast cancer.

脂肪细胞/肿瘤细胞通过 IGF-1/TXNIP 轴进行相互作用,促进乳腺癌的恶性转化和内分泌耐药性

Caruso Amanda, Accattatis Felice Maria, Giordano Cinzia, Gelsomino Luca, Del Console Piercarlo, Fiorita Maria Francesca, Gyorffy Balazs, Bianchi Laura, Carleo Alfonso, De Salvo Rossana, Simões Bruno M, Clarke Robert B, Memeo Lorenzo, Colarossi Cristina, Aiello Eleonora, Conforti Francesco, Fuqua Suzanne A W, Todaro Matilde, Stassi Giorgio, Morelli Catia, Sisci Diego, Bonofiglio Daniela, Catalano Stefania, Andò Sebastiano, Barone Ines